"Centre régional de référence en cancérologie, le Centre Eugène Marquis est un établissement privé d'intérêt collectif (ESPIC) à but non lucratif. Seul établissement de santé en Bretagne exclusivement dédié à la lutte contre le cancer, il fait partie du groupe UNICANCER réunissant les 18 Centres de Lutte Contre le Cancer de France. Le Centre Eugène Marquis est un lieu d'expertise, de savoirs faire, d'écoute et d'attention. Le patient est au cœur de notre métier. Tout au long du parcours de soin, des professionnels experts en cancérologie accompagnent, écoutent et mettent en œuvre une médecine personnalisée. Les médecins bénéficient d'un plateau technique performant et innovant avec un même objectif : un égal accès à des soins de qualité p"

During the past decade, Centre Eugene Marquis conducted 168 clinical trials. In the 10-year time frame, 168 clinical trials started and 45 clinical trials were completed, i.e. on average, 26.8% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 28 clinical trials were completed. i.e. 48.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Eugene Marquis" #1 sponsor was "UNICANCER" with 70 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 27 trials sponsored, "Center Eugene Marquis" with 19 trials sponsored, "Centre Leon Berard" with 16 trials sponsored and "Centre Oscar Lambret" with 16 trials sponsored. Other sponsors include 177 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Eugene Marquis" #1 collaborator was "AstraZeneca" with 17 trials as a collaborator, "National Cancer Institute, France" with 14 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "UNICANCER" with 7 trials as a collaborator and "Fondation ARC" with 5 trials as a collaborator. Other collaborators include 188 different institutions and companies that were collaborators in the rest 144 trials.

According to Clinical.Site data, the most researched conditions in "Centre Eugene Marquis" are "Breast Cancer" (47 trials), "Prostate Cancer" (17 trials), "Colorectal Cancer" (16 trials), "Ovarian Cancer" (12 trials) and "Hepatocellular Carcinoma" (10 trials). Many other conditions were trialed in "Centre Eugene Marquis" in a lesser frequency.

Most popular intervention types in "Centre Eugene Marquis" are "Drug" (231 trials), "Radiation" (45 trials), "Other" (44 trials), "Procedure" (38 trials) and "Biological" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "radiation therapy" (17 trials), "fluorouracil" (16 trials), "Paclitaxel" (13 trials) and "adjuvant therapy" (12 trials). Other intervention names were less common.

The vast majority of trials in "Centre Eugene Marquis" are 232 trials for "All" genders, 70 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Eugene Marquis". 4 are not yet recruiting, 64 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 159 completed trials in Centre Eugene Marquis, 2 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Eugene Marquis, 35 "Phase 1" clinical trials were conducted, 113 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 45 trials that are defined as “Not Applicable".

Centre Eugene Marquis has several departments that took part in Clinical trials: "Centre Eugene Marquis; Service d'oncologie" - 16 trials